MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
82.51%
Quick Ratio
82.51%
Cash Ratio
41.00%
Debt to Asset Ratio
110.27%
Unit: Thousand (K) dollars
Assets Breakdown
    • Operating lease right-of-use ass...
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Operating lease liabilities, non...
    • Others
Balance Sheets
2026-06-30
2025-09-30
2025-06-30
Cash and cash equivalents
6,463
12,243
21,576
Accounts receivable-Nonrelated Party
0
147
168
Accounts receivable-Related Party
557
1,597
3,524
Prepaid expenses and other current assets-Related Party
4,932
2,067
5,483
Prepaid expenses and other current assets-Nonrelated Party
1,055
2,104
1,770
Total current assets
13,007
18,158
32,521
Restricted cash
1,426
3,540
3,529
Property and equipment, net
11,433
18,691
19,593
Operating lease right-of-use assets
7,239
12,262
12,845
Other non-current assets
0
34
52
Total assets
33,105
52,685
68,540
Accounts payable
2,248
1,771
1,020
Accrued expenses and other current liabilities
4,082
5,103
3,628
Convertible notes - related party
3,993
-
-
Operating lease liabilities, current
3,492
5,153
4,979
Genefab sublease deferred income - related party
1,939
0
360
Deferred revenue - related party
11
-
-
Total current liabilities
15,765
12,027
9,987
Operating lease liabilities, non-current
12,741
24,968
26,332
Other non-current liabilities
8,000
7,569
7,569
Total liabilities
36,506
44,564
43,888
Common stock, 0.0001 par value 500,000,000 shares authorized as of both june30, 2026 and december31, 2025 31,144,754 and 30,879,355 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
3
3
3
Additional paid-in capital
372,139
352,223
350,628
Accumulated deficit
-375,543
-344,105
-325,979
Total stockholders equity (deficit)
-3,401
8,121
24,652
Total liabilities and stockholders equity (deficit)
33,105
52,685
68,540
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$6,463K (-70.05%↓ Y/Y)Prepaid expenses andother current...$4,932K (-10.05%↓ Y/Y)Prepaid expenses andother current...$1,055K (-40.40%↓ Y/Y)Accountsreceivable-Related Party$557K (-84.19%↓ Y/Y)Total current assets$13,007K (-60.00%↓ Y/Y)Property and equipment,net$11,433K (-41.65%↓ Y/Y)Operating leaseright-of-use assets$7,239K (-43.64%↓ Y/Y)Restricted cash$1,426K (-59.59%↓ Y/Y)Total assets$33,105K (-51.70%↓ Y/Y)Accumulated deficit-$375,543K (-15.20%↓ Y/Y)Total liabilities andstockholders equity...$33,105K (-51.70%↓ Y/Y)Total stockholdersequity (deficit)-$3,401K (-113.80%↓ Y/Y)Additional paid-in capital$372,139K (6.13%↑ Y/Y)Common stock, 0.0001par value...$3K (0.00%↑ Y/Y)Total liabilities$36,506K (-16.82%↓ Y/Y)Total currentliabilities$15,765K (57.86%↑ Y/Y)Operating leaseliabilities, non-current$12,741K (-51.61%↓ Y/Y)Other non-currentliabilities$8,000K (5.69%↑ Y/Y)Accrued expenses andother current...$4,082K (12.51%↑ Y/Y)Convertible notes - relatedparty$3,993K Operating leaseliabilities, current$3,492K (-29.87%↓ Y/Y)Accounts payable$2,248K (120.39%↑ Y/Y)Genefab subleasedeferred income - related...$1,939K (438.61%↑ Y/Y)Deferred revenue -related party$11K

Senti Biosciences Holdings, Inc. (SNTI)

Senti Biosciences Holdings, Inc. (SNTI)